Novo Nordisk (NVO) stock gains as the FDA approves the company's Wegovy pill, as Eli Lilly (LLY) awaits FDA review for its orforglipron obesity pill. Read more here.

Denmark on Thursday sharply raised its economic growth forecast for 2025, due in part to the pharmaceuticals industry, which is performing well, its economy minister said, despite recent layoffs at drug maker Novo Nordisk.

Denmark raised its growth projections for this year and the next, suggesting Novo Nordisk A/S is able to fuel the Nordic economy despite mounting pressures on the pharmaceutical heavyweight.

Weaker prospects for pharmaceutical giant Novo Nordisk A/S (NYSE:NVS) have prompted Denmark's economic ministry to cut its 2025 GDP forecast, now expecting just 1.4% growth, down 1.5 percentage points from May's projection. Growth is seen rebounding to 2.1 ...

Novo Nordisk Pharma Thailand Ltd. (“Novo Nordisk”) and the Embassy of Denmark in Bangkok have donated 430,000 THB (around 86,000 DKK) to the Diabetes Association of Thailand to support relief efforts following the major floods in southern Thailand.